249 related articles for article (PubMed ID: 3462448)
1. [Determination of carcinoembryonic and carbohydrate antigens in the diagnosis of recurrences and metastases of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1986 Aug; 31(8):40-4. PubMed ID: 3462448
[TBL] [Abstract][Full Text] [Related]
2. [Carbohydrate antigen (CA-19-9) in the blood serum of patients with benign and malignant liver diseases].
Ametov AS; Kasatkin IuN; Mit'kov VV; Gur'eva IV
Med Radiol (Mosk); 1985 Mar; 30(3):39-41. PubMed ID: 3856723
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunological determination of tumor markers in the diagnosis of recurrences of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1991; 36(10):17-20. PubMed ID: 1719331
[TBL] [Abstract][Full Text] [Related]
4. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
Yu BM
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
[TBL] [Abstract][Full Text] [Related]
6. CEA levels at recurrence and metastases; importance for detecting secondary disease.
Rieger A; Wahren B
Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
[TBL] [Abstract][Full Text] [Related]
7. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunologic determination of beta 2-microglobulin and carcinoembryonic antigen in the diagnosis of recurrences of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1986 Apr; 31(4):23-5. PubMed ID: 3515109
[TBL] [Abstract][Full Text] [Related]
9. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
[TBL] [Abstract][Full Text] [Related]
10. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
Ivanov PK; Samoĭlenko VM
Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigens and liver metastasis in colorectal cancer.
Hasegawa H; Watanabe M; Arisawa Y; Teramoto T; Kodaira S; Kitajima M
Jpn J Clin Oncol; 1993 Dec; 23(6):336-41. PubMed ID: 7904324
[TBL] [Abstract][Full Text] [Related]
12. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
Quentmeier A; Schlag P; Herfarth C
Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
[TBL] [Abstract][Full Text] [Related]
13. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
14. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
[No Abstract] [Full Text] [Related]
16. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
19. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
20. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
Safi F; Rappenecker B; Roscher R; Beger HG
Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
